Contact

Email

martin.vu@unimelb.edu.au

Credentials

Position
Professional Association
International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Education
Doctorate (Research)
University of Melbourne
Masters (Coursework)
University of Melbourne
Bachelors Degree
University of Melbourne
ORCID

0000-0001-5918-1692

Mr Martin Vu

University of Melbourne
16 Scholarly works
1 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Operationalizing the Wilson-Jungner principles for the genomics era: Consensus recommendations from the International Consortium on Newborn Sequencing
    DOI: 10.1016/j.gim.2025.101618
  • 2025

    Journal article

    Data-driven consideration of genetic disorders for global genomic newborn screening programs
    DOI: 10.1016/j.gim.2025.101443
  • 2024

    Journal article

    Scenario analysis and multi-criteria decision analysis to explore alternative reimbursement pathways for whole genome sequencing for blood cancer patients
    DOI: 10.1016/j.jcpo.2024.100501
  • 2024

    Journal article

    Economic Impact of Whole Genome Sequencing and Whole Transcriptome Sequencing Versus Routine Diagnostic Molecular Testing to Stratify Patients with B-Cell Acute Lymphoblastic Leukemia
    DOI: 10.1016/j.jmoldx.2024.04.006
  • 2024

    Journal article

    Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in Australia
    DOI: 10.1007/s40258-023-00826-4
  • 2023

    Thesis / Dissertation

    Economic analysis of next-generation sequencing for blood cancers: informing policy decision-making towards reimbursement
  • 2023

    Research contracts (non-grants)

    Health Economic Analysis of Performing Whole Genome Sequencing of Rare Cancers
Martin Vu

Latest Honours,
Awards and Fellowships

2021
The Picchi Brothers Foundation

RECENT SCHOLARLY WORKS

  • 2023

    Journal article

    Health Economic Evidence and Modeling Challenges for Liquid Biopsy Assays in Cancer Management: A Systematic Literature Review
    DOI: 10.1007/s40273-023-01292-5
  • 2022

    Conference Proceedings

    COST-EFFECTIVENESS OF TP53 AND IGHV BIOMARKER TESTING PRIOR TO FIRST-LINE TREATMENT WITH NOVEL AGENTS FOR CHRONIC LYMPHOCYTIC LEUKEMIA
    DOI: 10.1016/j.jval.2022.09.393
  • 2022

    Journal article

    Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review
    DOI: 10.1111/ejh.13755
  • 2021

    Conference Proceedings

    Diagnostic Utility of Multimodal Genomic Profiling for Molecular Classification and MRD Assessment in Adult B-Cell Acute Lymphoblastic Leukemia
    DOI: 10.1182/blood-2021-146396